Cite
The Effect of Treatment and Bone Metabolic Factors on Fracture Incidence in Patients with Thalassemia-Induced Osteoporosis: An Observational Study
MLA
Tsartsalis, Athanasios N., et al. “The Effect of Treatment and Bone Metabolic Factors on Fracture Incidence in Patients with Thalassemia-Induced Osteoporosis: An Observational Study.” Current Drug Therapy, vol. 15, no. 4, Aug. 2020, pp. 381–88. EBSCOhost, https://doi.org/10.2174/1574885515666200106110602.
APA
Tsartsalis, A. N., Lambrou, G. I., Vlachou, E., Samartzi, A., Chrousos, G. P., Kanaka-Gantenbein, C., & Kattamis, A. (2020). The Effect of Treatment and Bone Metabolic Factors on Fracture Incidence in Patients with Thalassemia-Induced Osteoporosis: An Observational Study. Current Drug Therapy, 15(4), 381–388. https://doi.org/10.2174/1574885515666200106110602
Chicago
Tsartsalis, Athanasios N., George I. Lambrou, Eugenia Vlachou, Athanasia Samartzi, George P. Chrousos, Christina Kanaka-Gantenbein, and Antonis Kattamis. 2020. “The Effect of Treatment and Bone Metabolic Factors on Fracture Incidence in Patients with Thalassemia-Induced Osteoporosis: An Observational Study.” Current Drug Therapy 15 (4): 381–88. doi:10.2174/1574885515666200106110602.